这款药是去年罗氏最叫卖的癌症治疗药品，在全球范围内销售收入高达59亿美元。
The drug was Roche's top-selling cancer treatment last year with global sales of $5.9 billion.
三月份，罗氏和生物基因艾迪克就研究中的新发现向美国食品药品监督管理局(Food and Drug Administration)提出新应用的申请。
In March, Roche and Biogen Idec filed an application with the U.S. Food and Drug Administration seeking expanded approval of Rituxan as reflected in the study's findings.
越南表示，如果不能和瑞士罗氏制药公司达成生产“达菲”药品协议的话，越南可能会自行生产抗禽流感病毒的“达菲”仿制品。
Vietnam says it may produce a generic version of the antiviral drug Tamiflu if a licensing agreement cannot be reached with the drug's Swiss manufacturer (Roche Holding ag).
应用推荐